source
- Zanubrutinib shows longer overall survival than ibrutinib in real-world relapsed/refractory mantle cell lymphomaA retrospective real‑world analysis examined outcomes of covalent BTK inhibitors in patients with relapsed or refractory mantle cell lymphoma who received treatment in the second or third line. Th…
- GSK partners with Sino Biopharma to expand access to hepatitis B drug bepirovirsen in ChinaGSK announced a marketing agreement with Sino Biopharmaceutical to distribute its experimental hepatitis B therapy bepirovirsen in China. Sino's subsidiary will purchase a supply of the drug and u…BioPharma Dive · 6mo agoDealPositive